Analogs of oxytocin conformationally restricted in the N-terminal part of the molecule

Journal of Peptide Research

Volumn 57, Issue 2, 2001, Pages 162-167

  Lempicka, E ^a   Derdowska, I ^a   Jastrzebska, B ^a   Lammek, B ^a   Kuncarova, P ^b   Slaninova, J ^b  

^a UNIVERSITY OF GDA SK   (Poland)

^b INSTITUTE OF ORGANIC CHEMISTRY AND BIOCHEMISTRY   (Czech Republic)

Author keywords

Conformational constraints; Oxytocin; Oxytocin antagonists

Indexed keywords

DIPEPTIDE; OXYTOCIN; OXYTOCIN ANTAGONIST;

AMINO TERMINAL SEQUENCE; ARTICLE; CHEMICAL MODIFICATION; CONFORMATION; DRUG ACTIVITY; DRUG RECEPTOR BINDING; DRUG STRUCTURE; PEPTIDE SYNTHESIS; PRIORITY JOURNAL;

ANIMALS; FEMALE; MALE; OXYTOCIN; PROTEIN CONFORMATION; RATS; RATS, WISTAR; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 0035132620     PISSN: 1397002X     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1399-3011.2001.00805.x     Document Type: Article

References (30)

1. Neurohypophyseal hormone receptor systems in brain periphery
2. Mechanisms of action of vasopressin and vasopressin antagonists
3. Discovery, development, and some uses of vasopressin and oxytocin antagonists
4. Pharmacology and clinical perspectives of vasopressin antagonists
5. Oxytocin antagonists in preterm labour and delivery
6. 1a receptors in uterine contraction in rats: Implications for tocolytic therapy with oxytocin antagonists
7. Substitution of the side-chain-constrained amino beta methyl-2,6-dimethyl-4-methoxytyrosine in position 2 of a bicyclic oxytocin analogue provides unique insights into the bioactive topography of oxytocin antagonists
8. Pharmacology and clinical perspectives of vasopressin antagonists
9. The 1- and 2-naphthylalanine analogs of oxytocin and vasopressin
10. Biologically active analogues of arginine vasopressin containing conformationally restricted dipeptide fragments
11. Design and synthesis of highly selective in vitro and in vivo uterine receptor antagonists of oxytocin: Comparisons with Atosiban
12. 1a receptor antagonists: New approaches for the design of potential tocolytics for preterm labor
13. Synthesis of modified analogs of 1-(1-phenylmethylthiocycloheksane)-acetic acid
14. A highly potent analogue of oxytocin, desamino-oxytocin
15. Linear antagonists of arginine vasopressin modified on their N-terminus
16. Color test for detection of free terminal amino groups in the solid-phase synthesis of peptides
17. A chloroanil color test for monitoring coupling completeness in solid phase peptide synthesis
18. Synthesis of oxytocin using iodine for oxidative cyclization and silica gel adsorption chromatography for purification
19. The purification of synthetic oxytocin and analogues by gel filtration on Sephadex G-15
20. A modification of the method of Dale and Laidlaw for standardization of posterior pituitary extract
21. Effect of magnesium ion on the response of the rat uterus to neurohypophysial hormones and analogues
22. The quantitative assay of vasopressin
23. Fundamental biological evaluation
24. Synthetic antagonists of in vivo responses by the rat uterus to oxytocin
25. [1-β-Mercapto-β,β-pentamethylenepropionic acid] oxytocin, a potent inhibitor of oxytocin
26. Synthèse d'analogues de l'oxytocine et de la lysine-vasopressine contenant de la phénylalanine ou de la tyrosine en positions 2 et 3
27. Synthesis of new oxytocin analogs with pentafluorophenylalanine at 2-position